Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 124.95 2.44% 2.98
SRPT closed up 2.44 percent on Friday, August 16, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical SRPT trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Calm After Storm Range Contraction 2.44%
Lower Bollinger Band Walk Weakness 2.44%
Outside Day Range Expansion 2.44%
Calm After Storm Range Contraction 1.10%
NR7 Range Contraction 1.10%
Lower Bollinger Band Walk Weakness 1.10%

Older signals for SRPT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Biotechnology Biopharmaceutical Life Sciences Biology Infectious Diseases Rare Diseases Duchenne Muscular Dystrophy Therapeutic Gene Modulation Antisense RNA
Is SRPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 165.87
52 Week Low 95.21
Average Volume 1,342,408
200-Day Moving Average 127.5366
50-Day Moving Average 139.2156
20-Day Moving Average 139.337
10-Day Moving Average 130.911
Average True Range 6.4452
ADX 31.23
+DI 10.09
-DI 33.9344
Chandelier Exit (Long, 3 ATRs ) 135.3644
Chandelier Exit (Short, 3 ATRs ) 134.3356
Upper Bollinger Band 159.9814
Lower Bollinger Band 118.6926
Percent B (%b) 0.15
BandWidth 29.63233
MACD Line -5.3574
MACD Signal Line -2.6316
MACD Histogram -2.7259
Fundamentals Value
Market Cap 8.03 Billion
Num Shares 64.2 Million
EPS -2.34
Price-to-Earnings (P/E) Ratio -53.40
Price-to-Sales 53.98
Price-to-Book 6.98
PEG Ratio 231.25
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 129.56
Resistance 3 (R3) 129.46 127.82 128.79
Resistance 2 (R2) 127.82 126.65 127.87 128.53
Resistance 1 (R1) 126.39 125.93 127.11 126.49 128.28
Pivot Point 124.75 124.75 125.11 124.80 124.75
Support 1 (S1) 123.32 123.58 124.04 123.42 121.62
Support 2 (S2) 121.68 122.86 121.73 121.37
Support 3 (S3) 120.25 121.68 121.11
Support 4 (S4) 120.35